Wajeeha Ansari

Wajeeha Ansari

Pfizer Inc. - New York / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 4545555
-
person_outline Wajeeha Ansari's MOST POPULAR ARTICLES
1-) Value of hospital antimicrobial stewardship programs [ASPs]: a systematic reviewD Nathwani, D Varghese, J Stephens, W Ansari, S Martin, ...Antimicrobial Resistance & Infection Control 8 (1), 1-13, 20191962019
2-) Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed …A Scott, R Chambers, M Reimbaeva, J Atwell, N Baillon-Plot, F Draica, ...Journal of Medical Economics 25 (1), 287-298, 2022112022
3-) Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19A Scott, W Ansari, F Khan, R Chambers, M Benigno, M Di Fusco, ...BMC medicine 22 (1), 46, 202492024
4-) Effect of nirmatrelvir/ritonavir versus placebo on COVID-19-related hospitalizations and other medical visitsJ Hammond, H Leister-Tebbe, A Gardner, P Abreu, W Bao, ...Open Forum Infectious Diseases 9 (2), ofac492. 047, 202262022
5-) Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre-to post-infectionIA Soare, W Ansari, JL Nguyen, D Mendes, W Ahmed, J Atkinson, A Scott, ...Health and Quality of Life Outcomes 22 (1), 12, 202452024